Treatment With Carbonic Anhydrase Inhibitor Acetazolamide Ameliorates Memory Impairments and Neuropathology in a Transgenic Model of Alzheimer’s Disease
Year: 2023
Type: article
Abstract: A series of recent observations are shedding light on the involvement of brain carbonic anhydrases (CAs) in neurodegenerative disorders: A higher expression of the CAII isoform was found in the plasma of Alzheimer’s Disease (AD) patients when compared to age-matched control subjects. Two CA inhibitors (CAIs) prevented Aβ-induced mitochondrial toxicity and cell death in vitro. Despite these encouraging findings, the impact of CAIs in AD animal models were not investigated. Here we evaluated the expression of the 15 CAs isoforms in the cortex and hippocampus of TgCRND8 mice (a transgenic AD model expressing the human amyloid precursor protein carrying the Swedish and Indiana mutations) at transcriptional level by RT-PCR.
Source: IBRO Neuroscience Reports
Institution: University of Florence
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W4388364004
